Best Practices in Obesity Model Selection and Study Design
Choosing the right preclinical rodent model for obesity research and drug development is complex and challenging. There’s a wide array of models available, with no one model perfect for all study types.
This White Paper shares best practices on selecting the most appropriate rodent model for preclinical obesity studies, providing detailed advantages and limitations of the available options. A series of case studies are included to highlight model selection based on different study aims and therapeutic mechanisms of action.
Download This White Paper to Understand:
- How to choose the right models and study design for preclinical anti-obesity agent drug development based on specific study goals and agent mechanism of action
- The applications and benefits of diet induced obesity (DIO) models, with vast historical data and ease of accessibility
- How to improve translatability of obesity drug development through next generation polygenic rodent models, better recapitulating clinical disease, progression, and comorbidities